ArticleJournal of athletic training2025
Pain is Modulated Differently Between Females With and Without Patellofemoral Pain: Factors Related to Sensitization.
Article in Journal of athletic training, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Adolescent patellofemoral pain syndrome: reappraisal of pathophysiology and implications for clinical management.Orthopedic reviews · 2026Article
- [Idiopathic anterior knee pain-what is the problem?]Orthopadie (Heidelberg, Germany) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
contextPatellofemoral pain (PFP) has poor long-term recovery outcomes. Central sensitization describes central nervous system changes altering pain modulation, which can complicate recovery (poorer prognosis and worse function). Signs of central sensitization include amplified pain facilitation, pain hypersensitivity, and impaired pain inhibition, which can be measured with temporal summation of pain (TSP), pressure pain thresholds (PPTs), and conditioned pain modulation (CPM), respectively. Sex differences exist for these test responses, but female-only PFP investigations of sensitization are uncommon. Understanding pain modulation in females with PFP could improve treatment protocols.
objectiveTo determine whether females with PFP exhibit signs of central sensitization (greater TSP, lower PPTs, and reduced CPM) compared with pain-free females.
designCross-sectional study.
settingLaboratory. PATIENTS OR OTHER
participantsThirty-three females ([20 PFP, 13 pain free]; age: PFP 29.2 ± 7 years, pain free 28 ± 7 years; height: PFP 166.7 ± 5.9 cm, pain free 166 ± 9.5 cm; mass: PFP 66.7 ± 9.6 kg, pain free 69.3 ± 7.5 kg). MAIN OUTCOME MEASURE(S): Temporal summation of pain was assessed with 10 punctate stimuli applied to the knee and calculated by the difference in pain intensity between beginning and end responses. Pressure pain thresholds were tested at 4 sites (3 for local hypersensitivity [knee] and 1 for widespread hypersensitivity [hand]). Conditioned pain modulation was conducted by comparing PPTs during 2 conditions (baseline and ice immersion). Conditioned pain modulation response was defined as the percent difference between conditions. Between-groups differences in TSP response were analyzed with a Welch test. Separate Welch tests analyzed group comparisons of PPTs and CPM responses at 4 sites.
resultsFemales with PFP exhibited greater TSP response (P = .019) and lower CPM response at patella center (P = .010) and hand sites (P = .007) than pain-free females. Pressure pain thresholds group differences were not observed at any site (P > .0125).
conclusionsFemales with PFP modulate pain differently than pain-free females. Clinicians should recognize signs of central sensitization and their potential effect on treatment options.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.